Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX.
Nagano N, Honjo M, Kawaguchi M, Nishimasu H, Nureki O, Kano K, Aoki J, Komatsu T, Okabe T, Kojima H, Nagano T, Aihara M.
Nagano N, et al. Among authors: kawaguchi m.
Biol Pharm Bull. 2019;42(11):1926-1935. doi: 10.1248/bpb.b19-00567.
Biol Pharm Bull. 2019.
PMID: 31685776
Free article.